Non-Small Cell Lung Cancer Coverage from Every Angle
Editor:
David S. Ettinger, MD
Advertisement
Advertisement

Ongoing CE Activities

Adding Local Tx Boosts Survival in Advanced NSCLC
Advanced/Metastatic NSCLC Treatment: Advancements for Patients Without Targetable Activating Mutations
Advanced Non-Small Cell Lung Ccancer Patient Management Simulator
ALK- or ROS1-Rearranged NSCLC: Effectively Integrating Precision Medicine into Patient-Centered Care
Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Lung Cancer
Consensus or Controversy? The Integration of Novel Therapies into the Interdisciplinary Management of Non-Small Cell Lung Cancer with CNS Metastases
Consensus or Controversy? Addressing Practical Clinical Questions Across the Metastatic Lung Cancer Continuum
Consensus or Controversy? Radiation and Medical Oncology Investigator Perspectives on the Role of Immune Checkpoint Inhibition in the Management of Locally Advanced Non–Small Cell Lung Cancer
Distilling Modern Medical Approaches in Advanced NSCLC: Precision, Performance, & Parallels with Patients
Enhancing Your Lung Cancer Practice: Applying Shared Decision Making in the Real-World
First-Line Therapy for Metastatic Non–Small Cell Lung Cancer: State-of-the-Art Targeted Therapy and Immunotherapy Approaches
Insights from the Latest Clinical Trials in Lung Cancer
Lung Cancer Update, Issue 1, 2020
Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care-Lung Cancer
NCCN Pharmacy Updates: Updates on the Use of Immunotherapy & Targeted Therapy in NSCLC
Novel and Emerging Therapeutic Strategies in the Management of Non–Small Cell Lung Cancer
Optimizing Immunotherapy in NSCLC: Updates from Trials on Agents Targeting PD-L1
Precision Management in Non-Small Cell Lung Cancer: Addressing ALK+ Tumors
Proceedings from the First Annual Oncology Nursing Retreat-Targeted Treatment of Lung Cancer
'Smart Nose' Identifies Anti-PD-1 Response in NSCLC
Targeting Epidermal Growth Factor Receptor in Non–Small Cell Lung Cancer: Advances in Treatment
Time to Tailor NSCLC RT to Spare the Immune System?
Visiting Professors: Lung Cancer Edition, Issue 1, 2019
Copyright © 2020 National Comprehensive Cancer Network, All Rights Reserved
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.